|
DE144266C
(enExample)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
PT1390040E
(pt)
|
2001-05-18 |
2007-04-30 |
Pantarhei Bioscience Bv |
Composição farmacêutica para ser utilizado na terapia hormonal de substituição.
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
EP1390041B1
(en)
|
2001-05-23 |
2009-11-25 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
CA2448278C
(en)
|
2001-05-23 |
2010-06-08 |
Christian Franz Holinka |
Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
EP1446128B1
(en)
|
2001-11-15 |
2006-12-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
EA007599B1
(ru)
|
2002-02-21 |
2006-12-29 |
Шеринг Акциенгезельшафт |
Фармацевтические композиции, содержащие один или несколько стероидов, один или несколько тетрагидрофолатных компонентов и витамин в
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CA2489270C
(en)
|
2002-06-11 |
2012-08-07 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
|
AU2003274946A1
(en)
|
2002-06-11 |
2003-12-22 |
Pantarhei Bioscience B.V. |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
|
|
ATE382356T1
(de)
|
2002-07-12 |
2008-01-15 |
Pantarhei Bioscience Bv |
Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
|
|
SI1556058T1
(sl)
|
2002-10-23 |
2008-02-29 |
Pantarhei Bioscience Bv |
Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
|
|
WO2004041839A2
(en)
|
2002-11-08 |
2004-05-21 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
|
DE602004002591T9
(de)
|
2003-05-22 |
2008-01-03 |
Pantarhei Bioscience B.V. |
Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
|
|
CN102796160A
(zh)
|
2005-05-26 |
2012-11-28 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
|
EP1910528A2
(de)
|
2005-07-25 |
2008-04-16 |
Technische Universität Dresden |
Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
CA2636638C
(en)
|
2006-01-09 |
2014-02-18 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
SG174785A1
(en)
|
2006-06-08 |
2011-10-28 |
Warner Chilcott Co Llc |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
TW200831139A
(en)
|
2006-11-29 |
2008-08-01 |
Wyeth Corp |
Estrogen/SERM and estrogen/progestin bi-layer tablets
|
|
CA2674776A1
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
DE602008001783D1
(de)
|
2007-01-08 |
2010-08-26 |
Pantarhei Bioscience Bv |
Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
|
|
MX2009007254A
(es)
|
2007-01-12 |
2009-08-12 |
Wyeth Corp |
Composiciones de tableta en tableta.
|
|
WO2008156365A1
(en)
|
2007-06-21 |
2008-12-24 |
Pantarhei Bioscience B.V. |
Treatment of meconium aspiration syndrome with estrogens
|
|
ES2376793T3
(es)
|
2007-07-19 |
2012-03-16 |
Pantarhei Bioscience B.V. |
Tratamiento o prevención de trastornos hipertensivos del embarazo o retraso del crecimiento fetal
|
|
WO2009028676A1
(ja)
|
2007-08-31 |
2009-03-05 |
National University Corporation Nagoya University |
カルボニル化合物の製造方法およびカルボニル化合物の製造に用いる酸化促進剤
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
WO2010033832A2
(en)
|
2008-09-19 |
2010-03-25 |
Evestra, Inc. |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
JP6425540B2
(ja)
|
2011-06-01 |
2018-11-21 |
エステトラ エス．ペ．エール．エル． |
エステトロール中間体を製造するための方法
|
|
EP2714712B1
(en)
|
2011-06-01 |
2016-08-24 |
Estetra S.P.R.L. |
Process for the production of estetrol intermediates
|
|
US10179107B2
(en)
|
2011-07-19 |
2019-01-15 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (DHEA)
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
SMT201700310T1
(it)
|
2011-08-11 |
2017-07-18 |
Estetra Sprl |
Uso dell'esterolo come contraccettivo di emergenza
|
|
US9731018B2
(en)
|
2011-09-16 |
2017-08-15 |
Ferring B.V. |
Fast dissolving pharmaceutical composition
|
|
SI2764008T1
(sl)
|
2011-10-07 |
2016-10-28 |
Estetra S.P.R.L. |
Postopek za pripravo estetrola
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6254289B2
(ja)
|
2013-09-18 |
2017-12-27 |
クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． |
エステトロールの製造プロセス
|
|
MA39105B1
(fr)
|
2013-12-12 |
2018-05-31 |
Donesta Bioscience B V |
Unité de dosage solide se désintégrant par voie orale contenant un constituant estétrol
|
|
HUE054551T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
|
|
NZ737948A
(en)
|
2015-06-18 |
2023-03-31 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
|
LT3310345T
(lt)
|
2015-06-18 |
2021-06-25 |
Estetra Sprl |
Burnoje disperguojama tabletė, turinti estetrolio
|
|
KR102662025B1
(ko)
|
2015-06-18 |
2024-05-02 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
에스테트롤 성분을 함유하는 구강분해성 투여 단위
|